First human test of new encapsulated cancer therapy begins
Disease control
Recruiting now
This is the first study in people to test a new cancer drug called FID-022. It aims to find a safe dose and see how the body processes the drug in up to 24 adults with advanced solid tumors that have no standard curative treatments. The drug is given through an IV and contains ch…
Phase: PHASE1 • Sponsor: Fulgent Pharma LLC. • Aim: Disease control
Last updated Mar 12, 2026 13:50 UTC